U.S. Aorto-iliac Occlusive Disease Treatment Market Summary The U.S. aorto-iliac occlusive disease (iliac disease) treatment market was valued at USD 716.6 million in 2024 and is anticipated to expand at a compound annual growth rate (CAGR) of 5.4% from 2025 to 2030. The market is primarily driven by the increasing prevalence of peripheral artery disease (PAD), growing governmental...